Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries

Claire E Otero1,2, Stephanie N Langel1,3, Maria Blasi1,4

  • 1Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.

Plos Pathogens
|November 19, 2020
PubMed
Summary

Maternal antibodies reduce rotavirus (RV) vaccine effectiveness in infants in lower-income countries. Further research, including animal models, is needed to understand and overcome this interference for better infant immunization.